Qingdao NovelBeam Technology Co. Ltd. A (688677) - Total Assets

Latest as of March 2026: CN¥1.63 Billion CNY ≈ $237.83 Million USD

Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) holds total assets worth CN¥1.63 Billion CNY (≈ $237.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Qingdao NovelBeam Technology Co. Ltd. A cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Qingdao NovelBeam Technology Co. Ltd. A - Total Assets Trend (2013–2025)

This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See Qingdao NovelBeam Technology Co. Ltd. A (688677) shareholders funds for net asset value and shareholders' equity analysis.

Qingdao NovelBeam Technology Co. Ltd. A - Asset Composition Analysis

Current Asset Composition (December 2025)

Qingdao NovelBeam Technology Co. Ltd. A's total assets of CN¥1.63 Billion consist of 63.2% current assets and 36.9% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 36.0%
Accounts Receivable CN¥106.67 Million 6.5%
Inventory CN¥260.38 Million 15.9%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥28.77 Million 1.8%
Goodwill CN¥3.61 Million 0.2%

Asset Composition Trend (2013–2025)

This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688677 market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Qingdao NovelBeam Technology Co. Ltd. A's current assets represent 63.2% of total assets in 2025, an increase from 40.1% in 2013.
  • Cash Position: Cash and equivalents constituted 36.0% of total assets in 2025, up from 14.5% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 11.0% in 2013.
  • Asset Diversification: The largest asset category is inventory at 15.9% of total assets.

Qingdao NovelBeam Technology Co. Ltd. A Competitors by Total Assets

Key competitors of Qingdao NovelBeam Technology Co. Ltd. A based on total assets are shown below.

Company Country Total Assets
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.12 Billion
Austco Healthcare Ltd
AU:AHC
Australia AU$91.07 Million
Ocumetics Technology Corp
V:OTC
Canada CA$1.15 Million
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
Trajan Group Holdings Ltd
AU:TRJ
Australia AU$192.32 Million
Osteopore Ltd
AU:OSX
Australia AU$2.77 Million
Nyxoah
BR:NYXH
Belgium €93.60 Million

Qingdao NovelBeam Technology Co. Ltd. A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.17 5.88 19.61
Quick Ratio 3.86 4.64 18.47
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥816.83 Million CN¥777.47 Million CN¥813.48 Million

Qingdao NovelBeam Technology Co. Ltd. A - Advanced Valuation Insights

This section examines the relationship between Qingdao NovelBeam Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 11.48
Latest Market Cap to Assets Ratio 0.78
Asset Growth Rate (YoY) 12.0%
Total Assets CN¥1.63 Billion
Market Capitalization $1.27 Billion USD

Valuation Analysis

Below Book Valuation: The market values Qingdao NovelBeam Technology Co. Ltd. A's assets below their book value (0.78x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Qingdao NovelBeam Technology Co. Ltd. A's assets grew by 12.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Qingdao NovelBeam Technology Co. Ltd. A (2013–2025)

The table below shows the annual total assets of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2025.

Year Total Assets Change
2025-12-31 CN¥1.63 Billion
≈ $239.21 Million
+11.96%
2024-12-31 CN¥1.46 Billion
≈ $213.66 Million
+4.68%
2023-12-31 CN¥1.39 Billion
≈ $204.11 Million
+0.09%
2022-12-31 CN¥1.39 Billion
≈ $203.92 Million
+17.92%
2021-12-31 CN¥1.18 Billion
≈ $172.93 Million
+183.19%
2020-12-31 CN¥417.31 Million
≈ $61.07 Million
+26.53%
2019-12-31 CN¥329.82 Million
≈ $48.26 Million
+20.86%
2018-12-31 CN¥272.90 Million
≈ $39.93 Million
+18.21%
2017-12-31 CN¥230.86 Million
≈ $33.78 Million
+9.30%
2016-12-31 CN¥211.21 Million
≈ $30.91 Million
+12.71%
2015-12-31 CN¥187.39 Million
≈ $27.42 Million
+13.34%
2014-12-31 CN¥165.34 Million
≈ $24.19 Million
+13.58%
2013-12-31 CN¥145.56 Million
≈ $21.30 Million
--

About Qingdao NovelBeam Technology Co. Ltd. A

SHG:688677 China Medical Instruments & Supplies
Market Cap
$1.27 Billion
CN¥8.69 Billion CNY
Market Cap Rank
#7790 Global
#1703 in China
Share Price
CN¥72.49
Change (1 day)
+7.78%
52-Week Range
CN¥36.31 - CN¥154.98
All Time High
CN¥154.98
About

Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more